This episode examines how the administration is expanding access to immigrant benefit data while promoting a narrative of falling prices that does not reflect the rising costs most Americans still face. It looks closely at the latest Epstein email releases, the large amount of unreleased digital evidence still held back by the Justice Department, and the political pressure building as Congress pushes for fuller transparency. It also breaks down the selective drug-pricing deals behind the administration’s economic message, the concerns raised about TrumpRx and its connections, and the broader pattern of shaping public perception while key information remains hidden. #EpsteinFiles #GovernmentTransparency #ImmigrationPolicy #EconomicReality #DrugPricing #CorporateInfluence #PublicAccountability #USPolitics #SystemicIssues #BehindTheScenes
